certican 0.25mg tablets
novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - everolimus - tablet - everolimus 0.25 mg - immunosuppressants
certican 0.75mg tablets
novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - everolimus - tablet - everolimus 0.75 mg - immunosuppressants
everolimus ascend 0.25 mg tablets
ascend gmbh c/o pollux business center gmbh sebastian-kneipp-straße 41, 60439 frankfurt am main, germany - tablet - everolimus 0.25 mg - immunosuppressants
everolimus ascend 0.5 mg tablets
ascend gmbh c/o pollux business center gmbh sebastian-kneipp-straße 41, 60439 frankfurt am main, germany - tablet - everolimus 0.5 mg - immunosuppressants
everolimus ascend 0.75 mg tablets
ascend gmbh c/o pollux business center gmbh sebastian-kneipp-straße 41, 60439 frankfurt am main, germany - tablet - everolimus 0.75 mg - immunosuppressants
everolimus ascend 1 mg tablets
ascend gmbh c/o pollux business center gmbh sebastian-kneipp-straße 41, 60439 frankfurt am main, germany - tablet - everolimus 1 mg - immunosuppressants
certican 0.1mg dispersible tablets
novartis ireland limited - everolimus (stabilised with bht) - dispersible tablet - 0.1 milligram(s) - selective immunosuppressants; everolimus
certican ® 0.1 mg dispersible tablets
novartis pharma services ag - everolimus 0.1 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.
certican ® 0.25 mg dispersible tablets
novartis pharma services ag - everolimus 0.25 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.
certican 0.5 mg tablets
novartis israel ltd - everolimus - tablets - everolimus 0.5 mg - everolimus - everolimus - kidney and heart transplantationcertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in adult patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.